Zhengye Biotechnology Holding Limited (ZYBT) P/E Ratio History
Insufficient DataValuation data unavailable. · Data 2026–2026
Loading P/E history...
P/E Ratio Analysis
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ZYBT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ZYBT Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
ZYBT P/E vs Peers
Animal health pharmaceuticals and vaccines peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $167M | 23.3Lowest | -Best | -40%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ZYBT — Frequently Asked Questions
Quick answers to the most common questions about buying ZYBT stock.
What is ZYBT's P/E ratio?
Zhengye Biotechnology Holding Limited (ZYBT) trailing twelve-month P/E ratio is N/A, based on TTM diluted EPS of N/A. The 5-year average P/E is N/A and the historical range spans N/A to N/A.
Is ZYBT stock overvalued or undervalued?
ZYBT current P/E: N/A. 5-year average P/E: N/A. Percentile: N/A.
Is ZYBT stock expensive?
ZYBT is fairly valued relative to its own history. The current P/E of N/A is near the 5-year average of N/A (N/A percentile of historical range).
What is ZYBT's historical P/E range?
Over the past 5 years, ZYBT's P/E ratio has ranged from N/A to N/A, with a median of N/A and an average of N/A. The current P/E of N/A places the stock at the N/A percentile of this range. Full historical data spans 2026–2026.
How does ZYBT's P/E compare to the S&P 500?
ZYBT current P/E: N/A. S&P 500 median P/E: 25.1x.
How does ZYBT's valuation compare to Healthcare peers?
Zhengye Biotechnology Holding Limited P/E of N/A can be benchmarked against Healthcare peers in the comparison table on this page.
What is ZYBT's PEG ratio?
ZYBT PEG ratio is N/A. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is ZYBT's earnings yield?
ZYBT earnings yield is N/A, the inverse of its N/A P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.